Find and Pitch Jounalists, Get Your Story Covered

	Profile	Recent Articles on Subject
1	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Semaglutide Does Not Increase Depression or Suicidal Ideation Risk in Adults With Overweight, Obesity - 9 days ago Pharmacist's Role in Duloxetine Therapy: Improving Medication Adherence in Older Adults With Depression, Pain - 11 days ago Study: Vitamin D Could Alleviate Negative Impacts of Monosodium Glutamate - 8 months ago FDA Approves Durvalumab Plus Chemotherapy to Treat Endometrial Cancer - 8 months ago J&J Submits sBLA To FDA for Guselkumab in Ulcerative Colitis - 12 months ago
2	Tara Haelle MedPage Today Sci/health journalist. Feminist. Educator. Photographer. Author. DFW science journalismhealthphotographyteaching	Studies Point to Several Options for Ulcerative Colitis After Anti-TNF Failure - 11 days ago
3	The Conversation Science Alert Science news. Official account. Australia science news	New Non-Opioid Painkiller First in Decades to Win FDA Approval - 17 days ago
4	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Vertex Pharma’s Opioid Alternative Wins FDA Approval, First in a New Class of Pain Meds - 23 days ago Teva and Sanofi Mid-Stage Data Reveal Shows Best-in-Class Potential for IBD Drug - 2 months ago
5	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Gabapentin May Not Raise the Risk of Falling After All - about 2 months ago Novel Agent Reduces Monthly Migraine Days - 6 months ago ALS Therapy to Be Pulled From the Market, Drugmaker Says - 11 months ago Novel Drug Approved for All Duchenne Muscular Dystrophy Variants - 11 months ago
6	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Neumora’s antidepressant stumbles in first Phase 3 trial readout - about 2 months ago STAT+: Axsome to send Alzheimer’s disease drug to FDA, despite mixed Phase 3 results - about 2 months ago
7	Kristen Monaco MedPage Today	Cymbalta Bottles Recalled; 1 in 3 Older Adults Are Lonely; Walking Off Depression - 2 months ago Novel Drug Improves Depression, Insomnia Symptoms as Add-On Therapy - 4 months ago FDA Rejects MDMA-Assisted Therapy for PTSD - 7 months ago Digital Therapies Compared; Summertime Sadness? Spravato Monotherapy Under Review - 7 months ago MDMA for PTSD Under FDA Review; GLP-1 for Opioid Cravings; ADHD an Evolutionary Aid? - about 1 year ago Another Mid-Stage Psychedelic Win; Gun Suicides Reach High; Magnetic Seizure Therapy - about 1 year ago
8	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	FDA Approves New Option for Rosacea - 4 months ago Cheap Antidepressant Flops for Severe Breathlessness in Trial - 5 months ago FDA Approves First Oral Option for Eosinophilic Esophagitis - about 1 year ago
9	Jessica Rendall CNET Journalist/Presenter @abcdarwin. Brisbane JournalismBroadcasting	Thousands of Antidepressant Bottles Were Recalled Over 'Impurity' Risk: Here's More Context - 4 months ago
10	David Nield Science Alert Freelance tech, science writer. Marple, Manchester, UK Technologysciencewriting	This Drug Shows Potential to Stop Migraines Before They Begin - 5 months ago

Journalists covering duloxetine